MARI — Marinomed Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00- €36.98m
- €46.21m
- €4.75m
- 39
- 90
- 95
- 92
Annual cashflow statement for Marinomed Biotech AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.01 | -5.89 | -6.4 | -6.79 | — |
| Depreciation | |||||
| Non-Cash Items | 0.443 | 1.58 | 1.43 | 1.62 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.75 | -1.17 | -0.904 | -0.03 | -2.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.88 | -4.87 | -5.2 | -4.53 | -2.5 |
| Capital Expenditures | -3.96 | -0.919 | -0.228 | -0.129 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | 0.02 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.96 | -0.919 | -0.207 | -0.129 | 0 |
| Financing Cash Flow Items | -0.012 | -0.001 | 0 | — | 1.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.01 | 2.38 | 7.78 | -0.93 | 1.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.81 | -3.4 | 2.37 | -5.59 | -0.9 |